Emerging Concepts for the Treatment of Hematological Malignancies with Therapeutic Monoclonal Antibodies

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|11|7|790-800

ISSN： 1389-4501

Source： Current Drug Targets, Vol.11, Iss.7, 2010-07, pp. : 790-800

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Monoclonal Antibodies in the Treatment of Hematologic Malignancies: Radiation Dosimetry Aspects

By  

Current Pharmaceutical Biotechnology, Vol. 2, Iss. 4, 2001-01 ,pp. : 351-356

Bentham Science Publishers

Access to resources Recommend Favorite

The Immunoproteasome as a Therapeutic Target for Hematological Malignancies

By  

Current Cancer Drug Targets, Vol. 14, Iss. 6, 2014-07 ,pp. : 537-548

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial [Hot topic: New and Emerging Drug Targets for the Treatment of Hematological Malignancies (Guest Editors: Dr. Linda J. Bendall)]

By  

Current Drug Targets, Vol. 11, Iss. 7, 2010-07 ,pp. : 767-768

Bentham Science Publishers

Access to resources Recommend Favorite

Proteasome Inhibition as a New Therapeutic Principle in Hematological Malignancies

By  

Current Drug Targets, Vol. 7, Iss. 10, 2006-10 ,pp. : 1341-1347

Bentham Science Publishers

Access to resources Recommend Favorite

The JAK-STAT Pathway: A Therapeutic Target in Hematological Malignancies

By  

Current Cancer Drug Targets, Vol. 6, Iss. 8, 2006-01 ,pp. : 671-679

Bentham Science Publishers

Access to resources Recommend Favorite